Formula K
Natural health product licensed in Canada
- Licence holder
- Eastwood Bio-Medical Research Inc.
- NPN or DIN-HM
- 80086678
- Status
- Active licence
- Licence date
- 27 June 2018
- Revision date
- Not provided
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Traditionnelle
If this product were sold in France
- Conditions légales
Glycyrrhiza glabra L.: La portion journalière recommandée ne doit pas conduire à une ingestion d'acide glycyrrhizinique supérieure à 100 mg. L'étiquetage doit comporter un avertissement avec la teneur suivante: "Ne pas utiliser pendant plus de 6 semaines sans avis médical." L'étiquetage doit comporter un avertissement déconseillant l'emploi chez les enfants.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Commiphora myrrha Source : Stem resin | 160 milligramme | Not calculated |
| Glycyrrhiza glabra Source : Racine | 160 milligramme | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Huile végétale, Copovidone
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 packet | 1 day |
Uses authorised in Canada
Balloon-flower, Wu wei zi, Mulbery leaf, Liquorice, and Chinese motherwort are a combination of Traditional Chinese Medicine Ingredients.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Do not use if you have gastrointestinal disorders such as inflammation or diarrhea. Discontinue use if gastrointestinal discomfort occurs. If symptoms persist or worsen, or if new symptoms develop, discontinue use and consult a health care practitioner. If you are taking prescription medications, consult a health care practitioner prior to use. Consult a health care practitioner prior to use if you have a liver disorder. Do not use if you have hypokalemia, high blood pressure, or a kidney or cardiovascular disorder. Do not use if you are taking thiazide diuretics, cardiac glycosides, corticosteriods, stimulant laxatives or other medications which may aggravate electrolyte imbalance.
- Contre-indications
Do not use if pregnant or breastfeeding. Consult a health care practitioner prior to use with insulin.
Source
Official Health Canada record, licence 80086678
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.